Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lovejoy

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Biomaterials|August 31, 2022
Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibitionMuhammad Ismail, Wen Yang, Yanfei Li, et al.
ACS Chemical Neuroscience|May 1, 2018
Stilbenes from Veratrum maackii Regel Protect against Ethanol-Induced DNA Damage in Mouse Cerebellum and Cerebral CortexYantong Wu, Shasha Li, Jinjin Liu, et al.
Molecular Pharmacology|October 18, 2012
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of actionGoldie Y L Lui, Peyman Obeidy, Samuel J Ford, et al.
Molecular Pharmacology|October 20, 2010
Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9Zufan Debebe, Tatyana Ammosova, Denitra Breuer, et al.
Nature Structural Biology|March 13, 1999
Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitorsB Lovejoy, A R Welch, S Carr, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 23, 2022
Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma ChemotherapyYan Zou, Yibin Wang, Sen Xu, et al.
Breast Cancer Research : BCR|October 28, 2020
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppressionBenjamin Heng, Ayse A Bilgin, David B Lovejoy, et al.
Biomacromolecules|April 19, 2019
Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug DeliveryGuoying Wang, Libing Fu, Adam Walker, et al.
British Journal of Cancer|January 8, 2009
ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cellsA Bohlken, B B Cheung, J L Bell, et al.
Journal of Medicinal Chemistry|August 7, 2012
Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivoDavid B Lovejoy, Danae M Sharp, Nicole Seebacher, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Biomaterials|August 31, 2022
Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibitionMuhammad Ismail, Wen Yang, Yanfei Li, et al.
ACS Chemical Neuroscience|May 1, 2018
Stilbenes from Veratrum maackii Regel Protect against Ethanol-Induced DNA Damage in Mouse Cerebellum and Cerebral CortexYantong Wu, Shasha Li, Jinjin Liu, et al.
Molecular Pharmacology|October 18, 2012
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of actionGoldie Y L Lui, Peyman Obeidy, Samuel J Ford, et al.
Molecular Pharmacology|October 20, 2010
Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9Zufan Debebe, Tatyana Ammosova, Denitra Breuer, et al.
Nature Structural Biology|March 13, 1999
Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitorsB Lovejoy, A R Welch, S Carr, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 23, 2022
Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma ChemotherapyYan Zou, Yibin Wang, Sen Xu, et al.
Breast Cancer Research : BCR|October 28, 2020
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppressionBenjamin Heng, Ayse A Bilgin, David B Lovejoy, et al.
Biomacromolecules|April 19, 2019
Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug DeliveryGuoying Wang, Libing Fu, Adam Walker, et al.
British Journal of Cancer|January 8, 2009
ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cellsA Bohlken, B B Cheung, J L Bell, et al.
Journal of Medicinal Chemistry|August 7, 2012
Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivoDavid B Lovejoy, Danae M Sharp, Nicole Seebacher, et al.
Pageof 8